DHR
DHR
NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks
$202.45
-1.44 (-0.71%)
As of Aug 15, 1:01 AM ET ·
Analyst Consensus
Strong Buy
32
Analysts
Very High
Coverage
Buy 27 84%
Hold 5 16%
Sell 0 0%
Price Target
Analyst Price Target -21.9% upside
Low Target $107.89
Average Target $158.11
High Target $252.83
Current Price $202.45
Current
$202.45
Target
$158.11
$107.89 $158.11 avg $252.83
Scenario Analysis
Bear Case
$107.89
-46.7%
Low target
Base Case
$158.11
-21.9%
Avg target
Bull Case
$252.83
+24.9%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$242.80
-16.6% from high
52-Week Low
$160.93
+25.8% from low
50-Day SMA
$227.23
-10.9% vs SMA
200-Day SMA
$209.48
-3.4% vs SMA
RSI (14)
39.9
Neutral
Target vs 52W High
$158.11
-34.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 36 81% $369.21 -37.2%
DHR
Danaher Corp
 Strong Buy 32 84% $158.11 -21.9%
A
Agilent Technologies Inc
 Strong Buy 29 76% $64.69 -56.4%
WAT
Waters Corp
 Hold 31 55% $189.60 -54.0%
IQV
Iqvia Holdings Inc
 Strong Buy 28 79% $82.96 -64.9%
ILMN
Illumina Inc
 Buy 28 61% $169.36 -11.3%
MTD
Mettler-Toledo International
 Hold 19 47% $170.43 -88.0%
WST
West Pharmaceutical Services
 Strong Buy 23 91% $136.24 -61.0%